Grossi F - Search Results

1

Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy.

Banna GL, Tiseo M, Cortinovis DL, Facchinetti F, Aerts JGJV, Baldessari C, Giusti R, Bria E, Grossi F, Berardi R, Morabito A, Catino A, Genova C, Mazzoni F, Gelibter A, Rastelli F, Macerelli M, Chiari R, Gori S, Mansueto G, Citarella F, Cantini L, Rijavec E, Bertolini F, Cappuzzo F, De Toma A, Friedlaender A, Metro G, Pensieri MV, Porzio G, Ficorella C, Pinato DJ, Cortellini A, Addeo A. Banna GL, et al. Among authors: grossi f. Thorac Cancer. 2022 Feb;13(3):483-488. doi: 10.1111/1759-7714.14256. Epub 2021 Dec 22. Thorac Cancer. 2022. PMID: 34939342 Free PMC article.

2

Phase II study of irinotecan and docetaxel in patients with previously treated non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 007).

Grossi F, Fasola G, Rossetto C, Spizzo R, Meduri S, Sibau A, Vigevani E, Tumolo S, Adami G, Sacco C, Recchia L, Rizzato S, Ceschia T, Belvedere O. Grossi F, et al. Lung Cancer. 2006 Apr;52(1):89-92. doi: 10.1016/j.lungcan.2005.11.013. Epub 2006 Feb 17. Lung Cancer. 2006. PMID: 16483688 Clinical Trial.

3

Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).

Grossi F, Tiseo M. Grossi F, et al. Crit Rev Oncol Hematol. 2006 Jun;58(3):221-30. doi: 10.1016/j.critrevonc.2005.09.002. Epub 2006 May 11. Crit Rev Oncol Hematol. 2006. PMID: 16697211 Review.

4

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.

Ardizzoni A, Cafferata MA, Tiseo M, Filiberti R, Marroni P, Grossi F, Paganuzzi M. Ardizzoni A, et al. Among authors: grossi f. Cancer. 2006 Dec 15;107(12):2842-9. doi: 10.1002/cncr.22330. Cancer. 2006. PMID: 17103443 Free article.

5

Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.

Grossi F, Aita M, Follador A, Defferrari C, Brianti A, Sinaccio G, Belvedere O. Grossi F, et al. Oncologist. 2007 Apr;12(4):451-64. doi: 10.1634/theoncologist.12-4-451. Oncologist. 2007. PMID: 17470688 Free article. Review.

6

Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study.

Gridelli C, Ferrara C, Guerriero C, Palazzo S, Grasso G, Pavese I, Satta F, Bajetta E, Cortinovis D, Barbieri F, Gebbia V, Grossi F, Novello S, Baldini E, Gasparini G, Latino W, Durante E, Giustini L, Negrini C. Gridelli C, et al. Among authors: grossi f. J Thorac Oncol. 2007 Jun;2(6):475-80. doi: 10.1097/01.JTO.0000275342.47584.f3. J Thorac Oncol. 2007. PMID: 17545841 Free article.

7

Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer.

Loprevite M, Tiseo M, Chiaramondia M, Capelletti M, Bozzetti C, Bortesi B, Naldi N, Nizzoli R, Dadati P, Kunkl A, Zennaro D, Lagrasta C, Campanini N, Spiritelli E, Camisa R, Grossi F, Rindi G, Franciosi V, Ardizzoni A. Loprevite M, et al. Among authors: grossi f. Clin Cancer Res. 2007 Nov 1;13(21):6518-26. doi: 10.1158/1078-0432.CCR-07-0805. Clin Cancer Res. 2007. PMID: 17975165

8

Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.

Tiseo M, Ardizzoni A, Cafferata MA, Loprevite M, Chiaramondia M, Filiberti R, Marroni P, Grossi F, Paganuzzi M. Tiseo M, et al. Among authors: grossi f. Anticancer Res. 2008 Jan-Feb;28(1B):507-13. Anticancer Res. 2008. PMID: 18383893 Free article.

9

Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression.

Rotondo R, Mastracci L, Piazza T, Barisione G, Fabbi M, Cassanello M, Costa R, Morandi B, Astigiano S, Cesario A, Sormani MP, Ferlazzo G, Grossi F, Ratto GB, Ferrini S, Frumento G. Rotondo R, et al. Among authors: grossi f. Int J Cancer. 2008 Sep 1;123(5):1108-16. doi: 10.1002/ijc.23437. Int J Cancer. 2008. PMID: 18528866

10

Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancer.

Aita M, Fasola G, Defferrari C, Brianti A, Bello MG, Follador A, Sinaccio G, Pronzato P, Grossi F. Aita M, et al. Among authors: grossi f. Crit Rev Oncol Hematol. 2008 Dec;68(3):183-96. doi: 10.1016/j.critrevonc.2008.05.002. Epub 2008 Jul 7. Crit Rev Oncol Hematol. 2008. PMID: 18606548 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters